The unanswered questions about GLP-1s for addiction care
Evidence is growing that GLP-1 receptor agonists, the drugs best known for treating diabetes and obesity, could also have a role in addiction care. A study published in March found that GLP-1 use was associated with 75% lower odds of any substance use disorder among adults with Type 2 diabetes or obesity. That included 74% […] The post The unanswered questions about GLP-1s for addiction care appeared first on Becker's Hospital Review | Healthcare News & Analysis.
Original Source
Read the full article at Beckershospitalreview →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.